Table 1.
Patient characteristics by baseline or post-implementation time period and by intervention or comparison hospitals
|
Comparison hospitals (n=28) |
Intervention hospitals (n=27) |
||||||
|---|---|---|---|---|---|---|---|
| Baseline | Post-implementation | Total | Baseline | Post-implementation | Total | ||
| Number of patients | 88 916 | 97 086 | 186 002 | 142 986 | 160 167 | 303 153 | |
| Age, years | 63·1 (17·7) | 63·6 (17·6) | 63·4 (17·6) | 57·0 (20·0) | 58·3 (19·8) | 57·7 (19·9) | |
| Sex* | |||||||
| Female | 45 344 (51·0%) | 49 762 (51·3%) | 95 106 (51·1%) | 67 066 (46·9%) | 76 862 (48·0%) | 143 928 (47·5%) | |
| Male | 43 572 (49·0%) | 47 323 (48·7%) | 90 895 (48·9%) | 75 920 (53·1%) | 83 305 (52·0%) | 159 225 (52·5%) | |
| Comorbidities | |||||||
| Acute myocardial infarction | 662 (0·7%) | 461 (0·5%) | 1123 (0·6%) | 1552 (1·1%) | 1744 (1·1%) | 3296 (1·1%) | |
| Congestive heart failure | 1871 (2·1%) | 1910 (2·0%) | 3781 (2·0%) | 4224 (3·0%) | 4878 (3·0%) | 9102 (3·0%) | |
| Cerebrovascular disease | 667 (0·8%) | 568 (0·6%) | 1235 (0·7%) | 1844 (1·3%) | 2200 (1·4%) | 4044 (1·3%) | |
| Dementia | 1652 (1·9%) | 1403 (1·4%) | 3055 (1·6%) | 3726 (2·6%) | 3599 (2·2%) | 7325 (2·4%) | |
| Chronic obstructive pulmonary disease | 1974 (2·2%) | 1905 (2·0%) | 3879 (2·1%) | 3579 (2·5%) | 5243 (3·3%) | 8822 (2·9%) | |
| Mild liver disease | 686 (0·8%) | 758 (0·8%) | 1444 (0·8%) | 3894 (2·7%) | 4092 (2·6%) | 7986 (2·6%) | |
| Diabetes | 8386 (9·4%) | 9129 (9·4%) | 17 515 (9·4%) | 12 136 (8·5%) | 12 890 (8·0%) | 25 026 (8·3%) | |
| Diabetes with complications | 4302 (4·8%) | 5995 (6·2%) | 10 297 (5·5%) | 12 566 (8·8%) | 17 024 (10·6%) | 29 590 (9·8%) | |
| Hemiplegia or paraplegia | 655 (0·7%) | 566 (0·6%) | 1221 (0·7%) | 3088 (2·2%) | 2938 (1·8%) | 6026 (2·0%) | |
| Renal disease | 3201 (3·6%) | 2359 (2·4%) | 5560 (3·0%) | 8154 (5·7%) | 6435 (4·0%) | 14 589 (4·8%) | |
| Cancer | 1366 (1·5%) | 1349 (1·4%) | 2715 (1·5%) | 1654 (1·2%) | 1730 (1·1%) | 3384 (1·1%) | |
| Metastatic cancer | 1804 (2·0%) | 1830 (1·9%) | 3634 (2·0%) | 3105 (2·2%) | 3625 (2·3%) | 6730 (2·2%) | |
Data are n (%) or mean (SD). Comorbidities present for fewer than 1% of patients are included in the analyses but excluded from this table. These include peripheral vascular disease, rheumatoid disease, peptic ulcer disease, moderate or severe liver disease, and AIDS.
*
Some values do not add up to the total; categorisations with fewer than ten individuals were suppressed to maintain confidentiality.